Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 167 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1661 5.2 months Advanced hepatocellular carcinoma 3 Chemotherapy
US Oncology Research, Inc. United States 8/2008
Treatment Details: Patients: This phase 2 study involved 21 patients with advanced liver cancer (hepatocellular carcinoma). The median age was 72, ranging from 44 to 88 years old. Most (81%) of the patients
 
1662 5.1 months Metastatic colorectal cancer 5 Biologic therapy
University of Chicago United States 5/2011
Treatment Details: Patients: This phase II study involved 19 patients with previously treated metastatic colorectal cancer. The median patient age was 64 years and 58% were male. Treatment: Patients were
 
1663 5.1 months Advanced hepatocellular carcinoma 4 Biologic therapy
AKH and Medizinische Universität Wien Austria 10/2008
Treatment Details: Patients: This phase 2 study involved 28 advanced hepatocellular carcinoma patients. The median patient age was 65 years and 86% were male. Treatment: Patients were treated with the bi
 
1664 5.1 months NHL 4 Biologic therapy
Dana-Farber Cancer Institute United States 8/2014
Treatment Details: Patients: This study involved 12 relapsed/refractory peripheral T cell lymphoma patients. The median patient age was 70.7 years and 50% were male. Treatment: Patients received biologic
 
1665 5.0 months Advanced malignant pleural mesothelioma 5 Biologic therapy
Emory University United States 1/2009
Treatment Details: Patients: This phase II study involved 13 previously treated advanced mesothelioma patients with a median age of 73 years; 8 were male. Treatment: Patients were treated with the biologi
 
1666 5.0 months Advanced hepatocellular carcinoma 4 Chemotherapy
Ain Shams University Egypt 9/2013
Treatment Details: Patients: This involved advanced hepatocellular carcinoma patients who were divided into two separate treatment groups. Group A had 26 patients with a median age of 53.5 years. Group B ha
 
1667 5.0 months Hepatocellular Carcinoma 4 Biologic therapy
Queen Mary Hospital China 1/2009
Treatment Details: Patients: This Phase 2 study involved 51 patients with hepatocellular carcinoma. Of these, 88% were male and the median age was 56 years with a range of 28-79. Treatment: Patients were
 
1668 5.0 months NSCLC with brain metastases 4 Chemotherapy
Radiation
Centre Hospitalier Lyon Sud France 6/2006
Treatment Details: Patients: This Phase II trial involved a total of 50 patients with advanced non-small-cell lung cancer with brain metastases. There were 40 men and 10 women. Subtypes included squamous cel
 
1669 5.0 months metastatic melanoma 3 Biologic therapy
City of Hope Comprehensive Cancer Center United States 9/2005
Treatment Details: Patients: This Phase II study involved 33 patients with metastatic melanoma. Treatment: The treatment consisted of a form of biological therapy - CCI-779, an analog of the immunosuppressi
 
1670 4.9 months Newly diagnosed GBM 3 Chemotherapy
Radiation
Stanford University United States 5/2001
Treatment Details: Patients: Fourteen patients with newly diagnosed gliomas were involved in this study. Nine patients had glioblastoma multiforme and five patients had anaplastic astrocytoma. Treatment: T
 
Page 167 of 187  | Previous Page  | Next Page